Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Wong

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinomaMatthew R Vernon, Mohit Maheshwari, Christopher J Schultz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Radiation-Induced Loss of Tumor-Reactive T Cells Calls for More Rationally Designed Radioimmunotherapy ApproachesImaad Said, Musaddiq J Awan, Stuart J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214Elizabeth M Gore, Kyounghwa Bae, Stuart J Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancerM Tracy Zundel, Michelle A Michel, Christopher J Schultz, et al.
Translational Cancer Research|June 17, 2024
Type I interferon signaling promotes radioresistance in head and neck cancerJoseph Zenga, Musaddiq J Awan, Anne Frei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation StudiesHisham Mehanna, Danny Rischin, Stuart J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysisAlexander Sun, Kyounghwa Bae, Elizabeth M Gore, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Phase 2 Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology Radiation Therapy Oncology Group Protocol 9911Corey J Langer, Jonathan Harris, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerStuart J Wong, Kathryn Winter, Neal J Meropol, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancerStuart J Wong, Jennifer Moughan, Neal J Meropol, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinomaMatthew R Vernon, Mohit Maheshwari, Christopher J Schultz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Radiation-Induced Loss of Tumor-Reactive T Cells Calls for More Rationally Designed Radioimmunotherapy ApproachesImaad Said, Musaddiq J Awan, Stuart J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214Elizabeth M Gore, Kyounghwa Bae, Stuart J Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancerM Tracy Zundel, Michelle A Michel, Christopher J Schultz, et al.
Translational Cancer Research|June 17, 2024
Type I interferon signaling promotes radioresistance in head and neck cancerJoseph Zenga, Musaddiq J Awan, Anne Frei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation StudiesHisham Mehanna, Danny Rischin, Stuart J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysisAlexander Sun, Kyounghwa Bae, Elizabeth M Gore, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Phase 2 Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology Radiation Therapy Oncology Group Protocol 9911Corey J Langer, Jonathan Harris, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerStuart J Wong, Kathryn Winter, Neal J Meropol, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancerStuart J Wong, Jennifer Moughan, Neal J Meropol, et al.
Pageof 5